Physician profile
Scott H Froum
NPI 1124240916
$100,398.45
in general payments reported to CMS, 2019-2025
6 companies · $13K in 2025
The $13K reported for 2025 was more than what 98% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,201 · 2020: $11K · 2021: $18K · 2022: $7,850 · 2023: $12K · 2024: $31K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,422 · Long Term Medical Supply Or Device Loan: $3,285 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Gift: $38.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,858.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,933.41 |
| Food and Beverage | $3,421.62 |
| Long Term Medical Supply Or Device Loan | $3,285.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Gift | $38.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convergent Dental INC. | $39,572.54 | 2024-2025 | Solea |
| Geistlich Pharma, North America, INC. | $33,830.93 | 2019-2025 | Bio-Gide, Bio-Oss, Biomaterials |
| Neoss, INC. | $26,798.20 | 2021-2024 | Neoss Implant System, Intra Oral Scanner |
| Align Technology, INC. | $89.93 | 2024 | Invisalign |
| Patterson Companies, INC. | $77.10 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $29.75 | 2019-2024 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Froum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.